GHEZZI, LAURA
GHEZZI, LAURA
Dipartimento di Scienze Biomediche, Chirurgiche ed Odontoiatriche
Targeting miR-223 enhances myeloid-derived suppressor cell suppressive activities in multiple sclerosis patients
2023 C. Cantoni, L. Ghezzi, J. Choi, A.H. Cross, L. Piccio
Twelve Weeks of Intermittent Caloric Restriction Diet Mitigates Neuroinflammation in Midlife Individuals with Multiple Sclerosis: A Pilot Study with Implications for Prevention of Alzheimer's Disease
2023 F. Rahmani, L. Ghezzi, V. Tosti, J. Liu, S. Song, A.T. Wu, J. Rajamanickam, K.A. Obert, T.L.S. Benzinger, B. Mittendorfer, L. Piccio, C.A. Raji
Why Is Multiple Sclerosis More Frequent in Women? Role of the Immune System and of Oral and Gut Microbiota
2023 M. D'Anca, F. Buccellato, G. Tartaglia, M. Del Fabbro, P. Muti, E. Scarpini, D. Galimberti, L. Ghezzi
Defects in lysosomal function and lipid metabolism in human microglia harboring a TREM2 loss of function mutation
2023 F. Filipello, S. You, F.S. Mirfakhar, S. Mahali, B. Bollman, M. Acquarone, O. Korvatska, J.A. Marsh, A. Sivaraman, R. Martinez, C. Cantoni, L. De Feo, L. Ghezzi, M.A. Minaya, A. Renganathan, A.G. Cashikar, J. Satoh, W. Beatty, A.K. Iyer, M. Cella, W.H. Raskind, L. Piccio, C.M. Karch
Schwann cell remyelination in the multiple sclerosis central nervous system
2023 L. Ghezzi, B. Bollman, L. De Feo, L. Piccio, B.D. Trapp, R.E. Schmidt, A.H. Cross
UNRAVELLING THE ROLE OF MUCOSAL ASSOCIATED INVARIANT T CELLS IN THE PATHOGENESIS OF MULTIPLE SCLEROSIS AND ITS ANIMAL MODEL
2022 L. Ghezzi
Alterations of host-gut microbiome interactions in multiple sclerosis
2022 C. Cantoni, Q. Lin, Y. Dorsett, L. Ghezzi, Z. Liu, Y. Pan, K. Chen, Y. Han, Z. Li, H. Xiao, M. Gormley, Y. Liu, S. Bokoliya, H. Panier, C. Suther, E. Evans, L. Deng, A. Locca, R. Mikesell, K. Obert, P. Newland, Y. Wu, A. Salter, A.H. Cross, P.I. Tarr, A. Lovett-Racke, L. Piccio, Y. Zhou
The influence of hormonal contraception on depression and female sexuality: a narrative review of the literature
2022 L. Buggio, G. Barbara, F. Facchin, L. Ghezzi, D. Dridi, P. Vercellini
The Gut Microbiome-Brain Crosstalk in Neurodegenerative Diseases
2022 L. Ghezzi, C. Cantoni, E. Rotondo, D. Galimberti
Energy restriction in people with multiple sclerosis: Is time more important than calories?
2022 L. Ghezzi
miRNA Expression Is Increased in Serum from Patients with Semantic Variant Primary Progressive Aphasia
2022 M. Serpente, L. Ghezzi, C. Fenoglio, F.R. Buccellato, G.G. Fumagalli, E. Rotondo, M. Arcaro, A. Arighi, D. Galimberti
Alterations of the gut mycobiome in patients with MS
2021 S. Shah, A. Locca, Y. Dorsett, C. Cantoni, L. Ghezzi, Q. Lin, S. Bokoliya, H. Panier, C. Suther, M. Gormley, Y. Liu, E. Evans, R. Mikesell, K. Obert, A. Salter, A.H. Cross, P.I. Tarr, A. Lovett-Racke, L. Piccio, Y. Zhou
Detection of the SQSTM1 Mutation in a Patient with Early-Onset Hippocampal Amnestic Syndrome
2021 T. Carandini, L. Sacchi, L. Ghezzi, A.M. Pietroboni, C. Fenoglio, A. Arighi, G.G. Fumagalli, M.A. De Riz, M. Serpente, E. Rotondo, E. Scarpini, D. Galimberti
Effects of dietary restriction on neuroinflammation in neurodegenerative diseases
2021 L. Fontana, L. Ghezzi, A.H. Cross, L. Piccio
Targeting the gut to treat multiple sclerosis
2021 L. Ghezzi, C. Cantoni, G.V. Pinget, Y. Zhou, L. Piccio
CSF β-amyloid predicts early cerebellar atrophy and is associated with a poor prognosis in multiple sclerosis
2020 A.M. Pietroboni, F. Schiano di Cola, A. Colombi, T. Carandini, C. Fenoglio, L. Ghezzi, M.A. De Riz, F. Triulzi, E. Scarpini, A. Padovani, D. Galimberti
Low CSF β-amyloid levels predict early regional grey matter atrophy in multiple sclerosis [Low CSF beta-amyloid levels predict early regional grey matter atrophy in multiple sclerosis]
2020 A.M. Pietroboni, A. Colombi, T. Carandini, V.E. Contarino, L. Ghezzi, G.G. Fumagalli, A. Arighi, C. Fenoglio, M.A. De Riz, F. Triulzi, E. Scarpini, D. Galimberti
Amyloid PET as a marker of normal-appearing white matter early damage in multiple sclerosis : correlation with CSF β-amyloid levels and brain volumes
2019 A.M. Pietroboni, T. Carandini, A. Colombi, M. Mercurio, L. Ghezzi, G. Giulietti, M. Scarioni, A. Arighi, C. Fenoglio, M.A. De Riz, G.G. Fumagalli, P. Basilico, M. Serpente, M. Bozzali, E. Scarpini, D. Galimberti, G. Marotta
The loss of macular ganglion cells begins from the early stages of disease and correlates with brain atrophy in multiple sclerosis patients
2019 A.M. Pietroboni, L. Dell'Arti, M. Caprioli, M. Scarioni, T. Carandini, A. Arighi, L. Ghezzi, G.G. Fumagalli, M.A. De Riz, P. Basilico, A. Colombi, E. Benatti, F. Triulzi, E. Scarpini, F. Viola, D. Galimberti
Cerebrospinal Fluid Level of Aquaporin4: A New Window on Glymphatic System Involvement in Neurodegenerative Disease?
2019 A. Arighi, A. Di Cristofori, C. Fenoglio, S. Borsa, M. D'Anca, G.G. Fumagalli, M. Locatelli, G. Carrabba, A.M. Pietroboni, L. Ghezzi, T. Carandini, A. Colombi, M. Scarioni, M.A. De Riz, M. Serpente, P.M. Rampini, E. Scarpini, D. Galimberti